Curis (CRIS) director John Hohneker receives 6,800 stock options at $5.29

Rhea-AI Filing Summary

CURIS INC director John Hohneker received a grant of 6,800 non-qualified stock options with an exercise price of $5.29 per share. These options relate to 6,800 shares of common stock and were awarded as a grant or other acquisition, not an open-market purchase or sale.

The options vest as to 100% of the underlying shares on July 7, 2027, and are scheduled to expire on July 6, 2036. Following this award, Hohneker holds 6,800 derivative securities directly in the form of these options.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Hohneker John

Role null

Type	Security	Shares	Price	Value
Grant/Award	Non Qualified Stock Option	6,800	$5.29	$36K

Holdings After Transaction: Non Qualified Stock Option — 6,800 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Options granted: 6,800 options Exercise price: $5.29 per share Underlying shares: 6,800 shares +3 more

6 metrics

Options granted 6,800 options Non-qualified stock option grant to director

Exercise price $5.29 per share Conversion or exercise price for options

Underlying shares 6,800 shares Common stock underlying granted options

Total derivative holdings 6,800 options Total derivative securities following transaction

Vesting date July 7, 2027 100% of underlying shares vest on this date

Expiration date July 6, 2036 Option expiration for this grant

Key Terms

Non Qualified Stock Option, grant/award acquisition, vesting, expiration date

4 terms

Non Qualified Stock Option financial

"security_title: "Non Qualified Stock Option""

grant/award acquisition financial

"transaction_action: "grant/award acquisition""

vesting financial

"vests as to 100% of the underlying shares on July 7, 2027"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

expiration date financial

"expiration_date: "2036-07-06T00:00:00.000Z""

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/09/2026 - 04:12 PM Accepted by SEC EDGAR 07/09/2026 - 04:12 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hohneker John

(Last) (First) (Middle)

128 SPRING STREET

BUILDING C - SUITE 500

(Street)

LEXINGTON MASSACHUSETTS 02421

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CURIS INC [ CRIS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non Qualified Stock Option	$5.29	07/07/2026		A		6,800		(1)	07/06/2036	Common Stock	6,800	$5.29	6,800	D

Explanation of Responses:

1. The option grant described in this Form 4 filing vests as to 100% of the underlying shares on July 7, 2027.

Remarks:

Exhibit Index: 24.1 Power of Attorney

	/s/ Diantha Duvall, Attorney-in-fact	07/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)